Providing Seed Capital For Growth

Karim Khaidi

Venture Analyst
Karim Khaidi is currently completing his B.S. in Biotechnology and Molecular Bioscience at Rochester Institute of Technology (RIT) with a minor in finance. At RIT, Karim engaged in multiple biotechnology researches including the development of high energy targeted molecular imaging agent for prostate cancer.

Karim is very passionate about equity research and portfolio management. Currently, he is responsible for managing the investment portfolio for the Financial Management Association at RIT which is worth over $150,000. He also regularly publishes his research on biotechnology related stocks on Seeking Alpha, a crowd-sourced investment research platform.

Excell Partners, Inc.
Excell Partners is an affiliate of the University of Rochester. It is a seed stage fund which invests in technologies emerging from the communities and universities across upstate New York. With over $14 million under management, Excell has invested in 48 companies across multiple industry sectors. Excell is one of only six venture firms in New York State to receive funding from ESDC's Innovate NY fund, and the only VC firm selected to manage the statewide MWBE Fund .